share_log

回盛生物:中信建投证券股份有限公司关于武汉回盛生物科技股份有限公司2023年度内部控制自我评价报告的核查意见

Huisheng Biotech: Verification Opinions of CITIC Construction Investment Securities Co., Ltd. on the 2023 Internal Control Self-Assessment Report of Wuhan Huisheng Biotechnology Co., Ltd.

Sensex a share ·  Apr 24
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more